logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 1
  • 1
    Morrison, James William
    Born in January 1985
    Individual (6 offsprings)
    Officer
    2021-03-03 ~ now
    OF - Director → CIF 0
    Mr James William Morrison
    Born in January 1985
    Individual (6 offsprings)
    Person with significant control
    2021-03-03 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
parent relation
Company in focus

CY BIOPHARMA LTD

Period: 2023-12-20 ~ now
Company number: 13241873
Registered names
CY BIOPHARMA LTD - now
SKYE BIOPHARMA LTD - 2023-12-20
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
21200 - Manufacture Of Pharmaceutical Preparations
Brief company account
Average Number of Employees
02024-01-01 ~ 2024-12-31
02023-01-01 ~ 2023-12-31
Debtors
Current
991,245 GBP2024-12-31
1,002,342 GBP2023-12-31
Cash at bank and in hand
15,042 GBP2024-12-31
7,497 GBP2023-12-31
Current Assets
1,006,287 GBP2024-12-31
1,009,839 GBP2023-12-31
Creditors
Current
9,237 GBP2024-12-31
10,620 GBP2023-12-31
Net Current Assets/Liabilities
997,050 GBP2024-12-31
999,219 GBP2023-12-31
Total Assets Less Current Liabilities
997,050 GBP2024-12-31
999,219 GBP2023-12-31
Equity
Called up share capital
1,000,000 GBP2024-12-31
1,000,000 GBP2023-12-31
Retained earnings (accumulated losses)
-2,950 GBP2024-12-31
-781 GBP2023-12-31
Equity
997,050 GBP2024-12-31
999,219 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
989,245 GBP2024-12-31
1,000,197 GBP2023-12-31
Other Debtors
Current
2,000 GBP2024-12-31
2,000 GBP2023-12-31
Debtors - Deferred Tax Asset
Current
145 GBP2023-12-31
Debtors
Amounts falling due within one year, Current
991,245 GBP2024-12-31
Current, Amounts falling due within one year
1,002,342 GBP2023-12-31
Trade Creditors/Trade Payables
Current
1,800 GBP2024-12-31
420 GBP2023-12-31
Amounts owed to group undertakings
Current
1,440 GBP2024-12-31
Corporation Tax Payable
Current
1,747 GBP2024-12-31
Accrued Liabilities
Current
4,250 GBP2024-12-31
10,200 GBP2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
12,000 GBP2024-12-31
24,000 GBP2023-12-31
Between one and five year
12,000 GBP2023-12-31
All periods
12,000 GBP2024-12-31
36,000 GBP2023-12-31

  • CY BIOPHARMA LTD
    Info
    SKYE BIOPHARMA LTD - 2023-12-20
    Registered number 13241873
    4th Floor, St. James House, St. James Square, Cheltenham GL50 3PR
    PRIVATE LIMITED COMPANY incorporated on 2021-03-03 (5 years 3 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-03-02
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.